NCT01177527View on ClinicalTrials.gov

Questionnaire and Tissue Banking For Multiple Myeloma, Waldenstrom Macroglobulinemia and Related Disorders

Active, not recruitingOBSERVATIONAL

Enrollment

656

Participants

Timeline

Start Date

December 31, 2009

Primary Completion Date

January 31, 2026

Study Completion Date

January 31, 2026

Conditions

Multiple MyelomaWaldenstrom's MacroglobulinemiaSmoldering Multiple MyelomaLymphoblastic Lymphoma

Trial Locations (1)

02115

Dana-Farber Cancer Institute, Boston

All Listed Sponsors

lead

Dana-Farber Cancer Institute

OTHER